Pedro M. Rodrigues has obtained a degree in Molecular and Cellular Biology from the New University of Lisbon (2011) and afterwards a Ph.D in Pharmacy in 2017, from the University of Lisbon (Portugal). In 2018, he joined the Liver Diseases group, at the Biogipuzkoa Health Research (San Sebastian, Spain), to carry out his postdoctoral studies, under the direction of Prof. Jesús M. Bañales. During this period, he has been deeply involved in the study of the molecular mechanisms that govern the development of liver tumors, searching for new therapeutic targets and non-invasive biomarkers. Currently, he is Head of the Metabolism & Cancer Group in the same institution, dedicating himself to the study of the molecular mechanisms that govern the progression of metabolic diseases towards liver cancer. He has received various national and international awards for his scientific career, such as the UEG Rising Star 2022 and AEEH Rising Star 2024 awards, from the United European Gastroenterology (UEG) and the Spanish Association for the Study of the Liver (AEEH), respectively, which distinguishes young (<40 years old) emerging leaders in the field of gastroenterology. Dr. Rodrigues was a member and Grant Awarding Coordinator in the COST EURO-CHOLANGIO-NET Action (2021-2023) and was a member of the UEG Young Talent Group (2020-2022). Currently, he is part of the EASL Young Investigator Task Force (2023-2026), coordinator of WG2 on the COST Precision-BTC-Network Action (2023-2027) and member of the Steering Committee of the European Network for the Study of CCA (ENSCCA; 2024-2028).
Pedro Rodrigues
